Rituximab in Antimelanoma Differentiation-Associated Protein-5 Dermatomyositis with Interstitial Lung Disease

In this paper, we report a challenging case of a middle-age woman who developed antimelanoma differentiation-associated protein-5 dermatomyositis (anti-MDA5 DM) with interstitial lung disease (ILD) and was successfully treated with rituximab (RTX), after failure of a first-line therapy.

Detalles Bibliográficos
Autores principales: Scirocco, Chiara, Gubbiotti, Andreina, Sebastiani, Alfredo, Sebastiani, Gian Domenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654211/
https://www.ncbi.nlm.nih.gov/pubmed/33204565
http://dx.doi.org/10.1155/2020/8145790
_version_ 1783608028462841856
author Scirocco, Chiara
Gubbiotti, Andreina
Sebastiani, Alfredo
Sebastiani, Gian Domenico
author_facet Scirocco, Chiara
Gubbiotti, Andreina
Sebastiani, Alfredo
Sebastiani, Gian Domenico
author_sort Scirocco, Chiara
collection PubMed
description In this paper, we report a challenging case of a middle-age woman who developed antimelanoma differentiation-associated protein-5 dermatomyositis (anti-MDA5 DM) with interstitial lung disease (ILD) and was successfully treated with rituximab (RTX), after failure of a first-line therapy.
format Online
Article
Text
id pubmed-7654211
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-76542112020-11-16 Rituximab in Antimelanoma Differentiation-Associated Protein-5 Dermatomyositis with Interstitial Lung Disease Scirocco, Chiara Gubbiotti, Andreina Sebastiani, Alfredo Sebastiani, Gian Domenico Case Rep Rheumatol Case Report In this paper, we report a challenging case of a middle-age woman who developed antimelanoma differentiation-associated protein-5 dermatomyositis (anti-MDA5 DM) with interstitial lung disease (ILD) and was successfully treated with rituximab (RTX), after failure of a first-line therapy. Hindawi 2020-05-30 /pmc/articles/PMC7654211/ /pubmed/33204565 http://dx.doi.org/10.1155/2020/8145790 Text en Copyright © 2020 Chiara Scirocco et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Scirocco, Chiara
Gubbiotti, Andreina
Sebastiani, Alfredo
Sebastiani, Gian Domenico
Rituximab in Antimelanoma Differentiation-Associated Protein-5 Dermatomyositis with Interstitial Lung Disease
title Rituximab in Antimelanoma Differentiation-Associated Protein-5 Dermatomyositis with Interstitial Lung Disease
title_full Rituximab in Antimelanoma Differentiation-Associated Protein-5 Dermatomyositis with Interstitial Lung Disease
title_fullStr Rituximab in Antimelanoma Differentiation-Associated Protein-5 Dermatomyositis with Interstitial Lung Disease
title_full_unstemmed Rituximab in Antimelanoma Differentiation-Associated Protein-5 Dermatomyositis with Interstitial Lung Disease
title_short Rituximab in Antimelanoma Differentiation-Associated Protein-5 Dermatomyositis with Interstitial Lung Disease
title_sort rituximab in antimelanoma differentiation-associated protein-5 dermatomyositis with interstitial lung disease
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654211/
https://www.ncbi.nlm.nih.gov/pubmed/33204565
http://dx.doi.org/10.1155/2020/8145790
work_keys_str_mv AT sciroccochiara rituximabinantimelanomadifferentiationassociatedprotein5dermatomyositiswithinterstitiallungdisease
AT gubbiottiandreina rituximabinantimelanomadifferentiationassociatedprotein5dermatomyositiswithinterstitiallungdisease
AT sebastianialfredo rituximabinantimelanomadifferentiationassociatedprotein5dermatomyositiswithinterstitiallungdisease
AT sebastianigiandomenico rituximabinantimelanomadifferentiationassociatedprotein5dermatomyositiswithinterstitiallungdisease

Ejemplares similares